Amyloid beta deposits, or plaques, in the brain are the most commonly hypothesized causative agent behind Alzheimer’s disease. A new breakthrough blood test, developed by an international team of scientists, can reportedly measure the concentration of these amyloid beta concentrations using just a tiny blood sample.
Alzheimer’s blood test promises detection years before symptoms develop
More of Today's Solutions
EU launches action plan to tackle cyberbullying and protect children’s mental...
BY THE OPTIMIST DAILY EDITORIAL TEAM As young people spend more of their lives online, the risks they face have become harder to ignore. ...
Read MoreBefore you buy: 6 smart questions to avoid impulse spending
BY THE OPTIMIST DAILY EDITORIAL TEAM We have all heard the advice: buy what you need, not what you want. In theory, it is ...
Read MoreRevumenib: the breakthrough pill curing leukemia in a third of patients
Patients with terminal leukemia who were not responding to treatment now have hope for a cure thanks to revumenib, a new experimental medication. In ...
Read MoreWhat is “weaponized kindness” and how can you protect your relationship from it?
In the delicate dance of love, kindness often serves as the melody that orchestrates harmony between couples. From modest gestures like morning coffees to ...
Read More
